{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:23:47Z","timestamp":1791404627521,"version":"4.3.3"},"reference-count":117,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"vor","delay-in-days":365,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Fund for Scientific Research in Industry and Agriculture (FRIA), Belgium"},{"name":"Universit\u00e9 catholique de Louvain (UCL), Belgium"},{"name":"\u201cFonds National de la Recherche Scientifique et M\u00e9dicale\u201d","award":["T.0105.14"],"award-info":[{"award-number":["T.0105.14"]}]},{"name":"\u201cAction de Recherche Concert\u00e9e\u201d, UCL, Belgium"},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.bbadis.2016.08.012","type":"journal-article","created":{"date-parts":[[2016,8,30]],"date-time":"2016-08-30T11:35:40Z","timestamp":1472556940000},"page":"2232-2243","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":77,"title":["O-GlcNAcylation, enemy or ally during cardiac hypertrophy development?"],"prefix":"10.1016","volume":"1862","author":[{"given":"Florence","family":"Mailleux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roselle","family":"G\u00e9linas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Beauloye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Horman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Bertrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2016.08.012_bb0005","doi-asserted-by":"crossref","first-page":"495349","DOI":"10.4061\/2011\/495349","article-title":"Left ventricular hypertrophy: major risk factor in patients with hypertension: update and practical clinical applications","volume":"2011","author":"Katholi","year":"2011","journal-title":"Int. J. Hypertens."},{"key":"10.1016\/j.bbadis.2016.08.012_bb0010","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1161\/01.CIR.102.4.470","article-title":"Left ventricular hypertrophy: pathogenesis, detection, and prognosis","volume":"102","author":"Lorell","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.bbadis.2016.08.012_bb0015","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1172\/JCI62839","article-title":"Signaling effectors underlying pathologic growth and remodeling of the heart","volume":"123","author":"van Berlo","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2016.08.012_bb0020","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nrm1983","article-title":"Regulation of cardiac hypertrophy by intracellular signalling pathways","volume":"7","author":"Heineke","year":"2006","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbadis.2016.08.012_bb0025","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1152\/physrev.00006.2004","article-title":"Myocardial substrate metabolism in the normal and failing heart","volume":"85","author":"Stanley","year":"2005","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bbadis.2016.08.012_bb0030","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1093\/cvr\/cvn282","article-title":"Metabolic remodelling of the failing heart: beneficial or detrimental?","volume":"81","author":"van Bilsen","year":"2009","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bbadis.2016.08.012_bb0035","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.pharmthera.2010.04.005","article-title":"Molecular distinction between physiological and pathological cardiac hypertrophy: experimental findings and therapeutic strategies","volume":"128","author":"Bernardo","year":"2010","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bbadis.2016.08.012_bb0040","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0006-291X(03)00175-X","article-title":"O-GlcNAc: a regulatory post-translational modification","volume":"302","author":"Wells","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbadis.2016.08.012_bb0045","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.bbagen.2009.07.018","article-title":"O-linked beta-N-acetylglucosamine (O-GlcNAc): extensive crosstalk with phosphorylation to regulate signaling and transcription in response to nutrients and stress","volume":"1800","author":"Butkinaree","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2016.08.012_bb0050","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/nrm3334","article-title":"Bittersweet memories: linking metabolism to epigenetics through O-GlcNAcylation","volume":"13","author":"Hanover","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbadis.2016.08.012_bb0055","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.yjmcc.2011.08.009","article-title":"Protein O-linked beta-N-acetylglucosamine: a novel effector of cardiomyocyte metabolism and function","volume":"52","author":"Darley-Usmar","year":"2012","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bbadis.2016.08.012_bb0060","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1002\/pmic.201400326","article-title":"Detection and identification of O-GlcNAcylated proteins by proteomic approaches","volume":"15","author":"Vercoutter-Edouart","year":"2015","journal-title":"Proteomics"},{"key":"10.1016\/j.bbadis.2016.08.012_bb0065","doi-asserted-by":"crossref","first-page":"30133","DOI":"10.1074\/jbc.M403773200","article-title":"Dynamic O-GlcNAc modification of nucleocytoplasmic proteins in response to stress. A survival response of mammalian cells","volume":"279","author":"Zachara","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2016.08.012_bb0070","doi-asserted-by":"crossref","first-page":"C178","DOI":"10.1152\/ajpcell.00162.2006","article-title":"Glucosamine protects neonatal cardiomyocytes from ischemia-reperfusion injury via increased protein-associated O-GlcNAc","volume":"292","author":"Champattanachai","year":"2007","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.bbadis.2016.08.012_bb0075","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1161\/CIRCRESAHA.108.189431","article-title":"Unique hexosaminidase reduces metabolic survival signal and sensitizes cardiac myocytes to hypoxia\/reoxygenation injury","volume":"104","author":"Ngoh","year":"2009","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbadis.2016.08.012_bb0080","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1146\/annurev-nutr-071812-161240","article-title":"O-GlcNAc cycling: a link between metabolism and chronic disease","volume":"33","author":"Bond","year":"2013","journal-title":"Annu. Rev. Nutr."},{"key":"10.1016\/j.bbadis.2016.08.012_bb0085","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/sj.neo.7900232","article-title":"c-Myc oncoprotein: a dual pathogenic role in neoplasia and cardiovascular diseases?","volume":"4","author":"Napoli","year":"2002","journal-title":"Neoplasia (New York, N.Y.)"},{"key":"10.1016\/j.bbadis.2016.08.012_bb0090","doi-asserted-by":"crossref","first-page":"18961","DOI":"10.1074\/jbc.270.32.18961","article-title":"c-Myc is glycosylated at threonine 58, a known phosphorylation site and a mutational hot spot in lymphomas","volume":"270","author":"Chou","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2016.08.012_bb0095","doi-asserted-by":"crossref","first-page":"3308","DOI":"10.1016\/S0021-9258(17)43295-9","article-title":"Topography and polypeptide distribution of terminal N-acetylglucosamine residues on the surfaces of intact lymphocytes. Evidence for O-linked GlcNAc","volume":"259","author":"Torres","year":"1984","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2016.08.012_bb0100","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1559-0275-11-8","article-title":"O-GlcNAc profiling: from proteins to proteomes","volume":"11","author":"Ma","year":"2014","journal-title":"Clin. Proteomics"},{"key":"10.1016\/j.bbadis.2016.08.012_bb0105","doi-asserted-by":"crossref","first-page":"5092","DOI":"10.1093\/emboj\/19.19.5092","article-title":"Decreased UDP-GlcNAc levels abrogate proliferation control in EMeg32-deficient cells","volume":"19","author":"Boehmelt","year":"2000","journal-title":"EMBO J."},{"key":"10.1016\/j.bbadis.2016.08.012_bb0110","doi-asserted-by":"crossref","first-page":"5849","DOI":"10.1128\/MCB.00802-07","article-title":"Agm1\/Pgm3-mediated sugar nucleotide synthesis is essential for hematopoiesis and development","volume":"27","author":"Greig","year":"2007","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbadis.2016.08.012_bb0115","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.pharmthera.2013.11.005","article-title":"O-GlcNAc and the cardiovascular system","volume":"142","author":"Dassanayaka","year":"2014","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bbadis.2016.08.012_bb0120","doi-asserted-by":"crossref","first-page":"19321","DOI":"10.1016\/S0021-9258(17)32170-1","article-title":"Purification and characterization of an O-GlcNAc selective N-acetyl-beta-d-glucosaminidase from rat spleen cytosol","volume":"269","author":"Dong","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2016.08.012_bb0125","doi-asserted-by":"crossref","first-page":"9838","DOI":"10.1074\/jbc.M010420200","article-title":"Dynamic O-glycosylation of nuclear and cytosolic proteins: cloning and characterization of a neutral, cytosolic beta-N-acetylglucosaminidase from human brain","volume":"276","author":"Gao","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2016.08.012_bb0130","doi-asserted-by":"crossref","first-page":"9308","DOI":"10.1074\/jbc.272.14.9308","article-title":"Dynamic glycosylation of nuclear and cytosolic proteins. Cloning and characterization of a unique O-GlcNAc transferase with multiple tetratricopeptide repeats","volume":"272","author":"Kreppel","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2016.08.012_bb0135","doi-asserted-by":"crossref","first-page":"7097","DOI":"10.1074\/jbc.M114.617779","article-title":"Conditional knock-out reveals a requirement for O-linked N-acetylglucosaminase (O-GlcNAcase) in metabolic homeostasis","volume":"290","author":"Keembiyehetty","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2016.08.012_bb0140","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1474-9726.2012.00801.x","article-title":"O-GlcNAcase is essential for embryonic development and maintenance of genomic stability","volume":"11","author":"Yang","year":"2012","journal-title":"Aging Cell"},{"key":"10.1016\/j.bbadis.2016.08.012_bb0145","doi-asserted-by":"crossref","first-page":"5735","DOI":"10.1073\/pnas.100471497","article-title":"The O-GlcNAc transferase gene resides on the X chromosome and is essential for embryonic stem cell viability and mouse ontogeny","volume":"97","author":"Shafi","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2016.08.012_bb0150","doi-asserted-by":"crossref","first-page":"4706","DOI":"10.1016\/S0021-9258(19)67706-9","article-title":"Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system. Role of hexosamine biosynthesis in the induction of insulin resistance","volume":"266","author":"Marshall","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2016.08.012_bb0155","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1021\/acschembio.5b00004","article-title":"A small molecule that inhibits OGT activity in cells","volume":"10","author":"Ortiz-Meoz","year":"2015","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.bbadis.2016.08.012_bb0160","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.1074\/jbc.273.6.3611","article-title":"Modulation of O-linked N-acetylglucosamine levels on nuclear and cytoplasmic proteins in vivo using the peptide O-GlcNAc-beta-N-acetylglucosaminidase inhibitor O-(2-acetamido-2-deoxy-D-glucopyranosylidene)amino-N-phenylcarbamate","volume":"273","author":"Haltiwanger","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2016.08.012_bb0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20131081","article-title":"Chemical tools to probe cellular O-GlcNAc signalling","volume":"456","author":"Ostrowski","year":"2013","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbadis.2016.08.012_bb0170","doi-asserted-by":"crossref","first-page":"25313","DOI":"10.1074\/jbc.M413819200","article-title":"O-GlcNAcase uses substrate-assisted catalysis: kinetic analysis and development of highly selective mechanism-inspired inhibitors","volume":"280","author":"Macauley","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2016.08.012_bb0175","doi-asserted-by":"crossref","first-page":"16484","DOI":"10.1021\/ja066743n","article-title":"GlcNAcstatin: a picomolar, selective O-GlcNAcase inhibitor that modulates intracellular O-glcNAcylation levels","volume":"128","author":"Dorfmueller","year":"2006","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bbadis.2016.08.012_bb0180","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/nchembio.96","article-title":"A potent mechanism-inspired O-GlcNAcase inhibitor that blocks phosphorylation of tau in vivo","volume":"4","author":"Yuzwa","year":"2008","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.bbadis.2016.08.012_bb0185","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.joca.2005.07.009","article-title":"Glucosamine oral bioavailability and plasma pharmacokinetics after increasing doses of crystalline glucosamine sulfate in man","volume":"13","author":"Persiani","year":"2005","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.bbadis.2016.08.012_bb0190","doi-asserted-by":"crossref","first-page":"H142","DOI":"10.1152\/ajpheart.00438.2013","article-title":"Cardiomyocyte Ogt is essential for postnatal viability","volume":"306","author":"Watson","year":"2014","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.bbadis.2016.08.012_bb0195","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.yjmcc.2008.04.009","article-title":"Non-canonical glycosyltransferase modulates post-hypoxic cardiac myocyte death and mitochondrial permeability transition","volume":"45","author":"Ngoh","year":"2008","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bbadis.2016.08.012_bb0200","doi-asserted-by":"crossref","first-page":"C1509","DOI":"10.1152\/ajpcell.00456.2007","article-title":"Glucosamine protects neonatal cardiomyocytes from ischemia-reperfusion injury via increased protein O-GlcNAc and increased mitochondrial Bcl-2","volume":"294","author":"Champattanachai","year":"2008","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.bbadis.2016.08.012_bb0205","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.yjmcc.2005.11.003","article-title":"Increased hexosamine biosynthesis and protein O-GlcNAc levels associated with myocardial protection against calcium paradox and ischemia","volume":"40","author":"Liu","year":"2006","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bbadis.2016.08.012_bb0210","doi-asserted-by":"crossref","first-page":"H2227","DOI":"10.1152\/ajpheart.01091.2006","article-title":"Glucosamine cardioprotection in perfused rat hearts associated with increased O-linked N-acetylglucosamine protein modification and altered p38 activation","volume":"292","author":"Fulop","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.bbadis.2016.08.012_bb0215","doi-asserted-by":"crossref","first-page":"H1391","DOI":"10.1152\/ajpheart.00285.2007","article-title":"Increased O-GlcNAc levels during reperfusion lead to improved functional recovery and reduced calpain proteolysis","volume":"293","author":"Liu","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.bbadis.2016.08.012_bb0220","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.yjmcc.2012.11.008","article-title":"Metabolic effects of glutamine on the heart: anaplerosis versus the hexosamine biosynthetic pathway","volume":"55","author":"Lauzier","year":"2013","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bbadis.2016.08.012_bb0225","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.yjmcc.2006.09.015","article-title":"Glutamine-induced protection of isolated rat heart from ischemia\/reperfusion injury is mediated via the hexosamine biosynthesis pathway and increased protein O-GlcNAc levels","volume":"42","author":"Liu","year":"2007","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bbadis.2016.08.012_bb0230","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1006\/jmcc.1998.0647","article-title":"Effects of l-glutamine on post-ischaemic cardiac function: protection and rescue","volume":"30","author":"Khogali","year":"1998","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bbadis.2016.08.012_bb0235","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1161\/CIRCULATIONAHA.107.730515","article-title":"Cardioprotection by N-acetylglucosamine linkage to cellular proteins","volume":"117","author":"Jones","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.bbadis.2016.08.012_bb0240","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1093\/cvr\/cvv136","article-title":"Interplay between troponin T phosphorylation and O-N-acetylglucosaminylation in ischaemic heart failure","volume":"107","author":"Dubois-Deruy","year":"2015","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bbadis.2016.08.012_bb0245","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1111\/jcmm.12112","article-title":"Circulating plasma serine208-phosphorylated troponin T levels are indicator of cardiac dysfunction","volume":"17","author":"Dubois-Deruy","year":"2013","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.bbadis.2016.08.012_bb0250","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/01.shk.0000245031.31859.29","article-title":"The protective effects of PUGNAc on cardiac function after trauma-hemorrhage are mediated via increased protein O-GlcNAc levels","volume":"27","author":"Zou","year":"2007","journal-title":"Shock (Augusta, Ga.)"},{"key":"10.1016\/j.bbadis.2016.08.012_bb0255","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1097\/01.shk.0000209563.07693.db","article-title":"Glucosamine administration during resuscitation improves organ function after trauma hemorrhage","volume":"25","author":"Yang","year":"2006","journal-title":"Shock (Augusta, Ga.)"},{"key":"10.1016\/j.bbadis.2016.08.012_bb0260","doi-asserted-by":"crossref","first-page":"H515","DOI":"10.1152\/ajpheart.01025.2008","article-title":"Glucosamine improves cardiac function following trauma-hemorrhage by increased protein O-GlcNAcylation and attenuation of NF-{kappa}B signaling","volume":"296","author":"Zou","year":"2009","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.bbadis.2016.08.012_bb0265","doi-asserted-by":"crossref","first-page":"44230","DOI":"10.1074\/jbc.M303810200","article-title":"Diabetes and the accompanying hyperglycemia impairs cardiomyocyte calcium cycling through increased nuclear O-GlcNAcylation","volume":"278","author":"Clark","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2016.08.012_bb0270","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1161\/01.RES.0000165478.06813.58","article-title":"Adenovirus-mediated overexpression of O-GlcNAcase improves contractile function in the diabetic heart","volume":"96","author":"Hu","year":"2005","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbadis.2016.08.012_bb0275","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1093\/glycob\/cwq071","article-title":"Inhibition of phospholamban phosphorylation by O-GlcNAcylation: implications for diabetic cardiomyopathy","volume":"20","author":"Yokoe","year":"2010","journal-title":"Glycobiology"},{"key":"10.1016\/j.bbadis.2016.08.012_bb0280","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1152\/physiolgenomics.00016.2011","article-title":"Cardiac O-GlcNAc signaling is increased in hypertrophy and heart failure","volume":"44","author":"Lunde","year":"2012","journal-title":"Physiol. Genomics"},{"key":"10.1016\/j.bbadis.2016.08.012_bb0285","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1161\/CIRCHEARTFAILURE.114.001151","article-title":"Metabolomic analysis of pressure-overloaded and infarcted mouse hearts","volume":"7","author":"Sansbury","year":"2014","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.bbadis.2016.08.012_bb0290","doi-asserted-by":"crossref","first-page":"e0135262","DOI":"10.1371\/journal.pone.0135262","article-title":"c-Myc alters substrate utilization and O-GlcNAc protein posttranslational modifications without altering cardiac function during early aortic constriction","volume":"10","author":"Ledee","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2016.08.012_bb0295","doi-asserted-by":"crossref","first-page":"H2122","DOI":"10.1152\/ajpheart.00775.2011","article-title":"O-GlcNAc signaling is essential for NFAT-mediated transcriptional reprogramming during cardiomyocyte hypertrophy","volume":"302","author":"Facundo","year":"2012","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.bbadis.2016.08.012_bb0300","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.15252\/emmm.201404669","article-title":"Cardiac LXRalpha protects against pathological cardiac hypertrophy and dysfunction by enhancing glucose uptake and utilization","volume":"7","author":"Cannon","year":"2015","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.bbadis.2016.08.012_bb0305","doi-asserted-by":"crossref","first-page":"17797","DOI":"10.1073\/pnas.1001907107","article-title":"O-linked beta-N-acetylglucosamine transferase is indispensable in the failing heart","volume":"107","author":"Watson","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2016.08.012_bb0310","first-page":"251","article-title":"Proposed regulation of gene expression by glucose in rodent heart","volume":"1","author":"Young","year":"2007","journal-title":"Gene Regul. Syst. Biol."},{"key":"10.1016\/j.bbadis.2016.08.012_bb0315","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s00726-013-1504-2","article-title":"O-GlcNAcylation involvement in high glucose-induced cardiac hypertrophy via ERK1\/2 and cyclin D2","volume":"45","author":"Ding","year":"2013","journal-title":"Amino Acids"},{"key":"10.1016\/j.bbadis.2016.08.012_bb0320","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/j.amjcard.2008.02.082","article-title":"Association between diabetes mellitus and left ventricular hypertrophy in a multiethnic population","volume":"101","author":"Eguchi","year":"2008","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.bbadis.2016.08.012_bb0325","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1016\/S0735-1097(99)00436-2","article-title":"Abnormal cardiac function in the streptozotocin-induced non-insulin-dependent diabetic rat: noninvasive assessment with doppler echocardiography and contribution of the nitric oxide pathway","volume":"34","author":"Joffe","year":"1999","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bbadis.2016.08.012_bb0330","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.lfs.2012.06.011","article-title":"Cardiac O-GlcNAcylation blunts autophagic signaling in the diabetic heart","volume":"92","author":"Marsh","year":"2013","journal-title":"Life Sci."},{"key":"10.1016\/j.bbadis.2016.08.012_bb0335","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.2337\/diabetes.51.12.3461","article-title":"Hyperglycemia inhibits capacitative calcium entry and hypertrophy in neonatal cardiomyocytes","volume":"51","author":"Pang","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.bbadis.2016.08.012_bb0340","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s00726-010-0699-8","article-title":"Activation of the hexosamine biosynthesis pathway and protein O-GlcNAcylation modulate hypertrophic and cell signaling pathways in cardiomyocytes from diabetic mice","volume":"40","author":"Marsh","year":"2011","journal-title":"Amino Acids"},{"key":"10.1016\/j.bbadis.2016.08.012_bb0345","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1152\/japplphysiol.00147.2011","article-title":"Swim-exercised mice show a decreased level of protein O-GlcNAcylation and expression of O-GlcNAc transferase in heart","volume":"111","author":"Belke","year":"2011","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.bbadis.2016.08.012_bb0350","doi-asserted-by":"crossref","first-page":"H114","DOI":"10.1152\/ajpheart.00135.2013","article-title":"Immediate effects of a single exercise bout on protein O-GlcNAcylation and chromatin regulation of cardiac hypertrophy","volume":"305","author":"Medford","year":"2013","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.bbadis.2016.08.012_bb0355","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1152\/physiolgenomics.00111.2012","article-title":"Enhanced cardiac protein glycosylation (O-GlcNAc) of selected mitochondrial proteins in rats artificially selected for low running capacity","volume":"45","author":"Johnsen","year":"2013","journal-title":"Physiol. Genomics"},{"key":"10.1016\/j.bbadis.2016.08.012_bb0360","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.lfs.2012.09.007","article-title":"Exercise training mitigates aberrant cardiac protein O-GlcNAcylation in streptozotocin-induced diabetic mice","volume":"92","author":"Bennett","year":"2013","journal-title":"Life Sci."},{"key":"10.1016\/j.bbadis.2016.08.012_bb0365","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/1475-2840-12-101","article-title":"Exercise and diabetes have opposite effects on the assembly and O-GlcNAc modification of the mSin3A\/HDAC1\/2 complex in the heart","volume":"12","author":"Cox","year":"2013","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.bbadis.2016.08.012_bb0370","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1161\/CIRCRESAHA.108.184978","article-title":"O-linked GlcNAc modification of cardiac myofilament proteins: a novel regulator of myocardial contractile function","volume":"103","author":"Ramirez-Correa","year":"2008","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbadis.2016.08.012_bb0375","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.2337\/db14-1107","article-title":"Removal of abnormal myofilament O-GlcNAcylation restores Ca2+ sensitivity in diabetic cardiac muscle","volume":"64","author":"Ramirez-Correa","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.bbadis.2016.08.012_bb0380","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.bbrc.2007.11.161","article-title":"The Ca2+ ATPase of cardiac sarcoplasmic reticulum: physiological role and relevance to diseases","volume":"369","author":"Inesi","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbadis.2016.08.012_bb0385","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1242\/jcs.114.12.2223","article-title":"Mechanisms of capacitative calcium entry","volume":"114","author":"Putney","year":"2001","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bbadis.2016.08.012_bb0390","doi-asserted-by":"crossref","first-page":"14266","DOI":"10.1074\/jbc.M107167200","article-title":"Capacitative calcium entry contributes to nuclear factor of activated T-cells nuclear translocation and hypertrophy in cardiomyocytes","volume":"277","author":"Hunton","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2016.08.012_bb0395","doi-asserted-by":"crossref","first-page":"C57","DOI":"10.1152\/ajpcell.00263.2005","article-title":"Glucosamine inhibits angiotensin II-induced cytoplasmic Ca2+ elevation in neonatal cardiomyocytes via protein-associated O-linked N-acetylglucosamine","volume":"290","author":"Nagy","year":"2006","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.bbadis.2016.08.012_bb0400","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1161\/CIRCULATIONAHA.111.031229","article-title":"Critical role for stromal interaction molecule 1 in cardiac hypertrophy","volume":"124","author":"Hulot","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.bbadis.2016.08.012_bb0405","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1161\/CIRCULATIONAHA.115.020678","article-title":"Cardiac Stim1 silencing impairs adaptive hypertrophy and promotes heart failure through inactivation of mTORC2\/Akt signaling","volume":"133","author":"Benard","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.bbadis.2016.08.012_bb0410","doi-asserted-by":"crossref","first-page":"39094","DOI":"10.1074\/jbc.M112.383778","article-title":"Modification of STIM1 by O-linked N-acetylglucosamine (O-GlcNAc) attenuates store-operated calcium entry in neonatal cardiomyocytes","volume":"287","author":"Zhu-Mauldin","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2016.08.012_bb0415","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/nature12537","article-title":"Diabetic hyperglycaemia activates CaMKII and arrhythmias by O-linked glycosylation","volume":"502","author":"Erickson","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2016.08.012_bb0420","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1038\/sj.emboj.7601252","article-title":"Hypertrophic growth in cardiac myocytes is mediated by Myc through a cyclin D2-dependent pathway","volume":"25","author":"Zhong","year":"2006","journal-title":"EMBO J."},{"key":"10.1016\/j.bbadis.2016.08.012_bb0425","doi-asserted-by":"crossref","first-page":"e7172","DOI":"10.1371\/journal.pone.0007172","article-title":"Cell cycle re-entry and mitochondrial defects in myc-mediated hypertrophic cardiomyopathy and heart failure","volume":"4","author":"Lee","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2016.08.012_bb0430","doi-asserted-by":"crossref","first-page":"4417","DOI":"10.1073\/pnas.92.10.4417","article-title":"Glycosylation of the c-Myc transactivation domain","volume":"92","author":"Chou","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2016.08.012_bb0435","author":"Swamy"},{"key":"10.1016\/j.bbadis.2016.08.012_bb0440","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0008-6363(01)00218-8","article-title":"On the trail of cardiac specific transcription factors","volume":"50","author":"Flesch","year":"2001","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bbadis.2016.08.012_bb0445","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1074\/jbc.270.1.410","volume":"270","author":"Karns","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2016.08.012_bb0450","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1128\/MCB.17.5.2550","article-title":"Reduced O glycosylation of Sp1 is associated with increased proteasome susceptibility","volume":"17","author":"Han","year":"1997","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbadis.2016.08.012_bb0455","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.bbrc.2015.10.096","article-title":"O-linked N-acetylglucosaminylation of Sp1 interferes with Sp1 activation of glycolytic genes","volume":"468","author":"Lim","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbadis.2016.08.012_bb0460","doi-asserted-by":"crossref","first-page":"6611","DOI":"10.1073\/pnas.111099998","article-title":"O-linkage of N-acetylglucosamine to Sp1 activation domain inhibits its transcriptional capability","volume":"98","author":"Yang","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2016.08.012_bb0465","doi-asserted-by":"crossref","first-page":"C794","DOI":"10.1152\/ajpcell.00251.2013","article-title":"Role for high-glucose-induced protein O-GlcNAcylation in stimulating cardiac fibroblast collagen synthesis","volume":"306","author":"Aguilar","year":"2014","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.bbadis.2016.08.012_bb0470","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/cvr\/cvp180","article-title":"Liver X receptors are negative regulators of cardiac hypertrophy via suppressing NF-kappaB signalling","volume":"84","author":"Wu","year":"2009","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bbadis.2016.08.012_bb0475","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0022-2828(03)00145-7","article-title":"NADPH oxidase-derived superoxide anion mediates angiotensin II-induced cardiac hypertrophy","volume":"35","author":"Nakagami","year":"2003","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bbadis.2016.08.012_bb0480","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1161\/01.CIR.98.8.794","article-title":"Inhibitory effects of antioxidants on neonatal rat cardiac myocyte hypertrophy induced by tumor necrosis factor-alpha and angiotensin II","volume":"98","author":"Nakamura","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.bbadis.2016.08.012_bb0485","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1161\/01.HYP.0000024348.87637.6F","article-title":"Simvastatin prevents angiotensin II-induced cardiac alteration and oxidative stress","volume":"40","author":"Delbosc","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.bbadis.2016.08.012_bb0490","doi-asserted-by":"crossref","first-page":"E713","DOI":"10.1152\/ajpendo.00108.2011","article-title":"O-linked beta-N-acetylglucosamine supports p38 MAPK activation by high glucose in glomerular mesangial cells","volume":"301","author":"Goldberg","year":"2011","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"2012","key":"10.1016\/j.bbadis.2016.08.012_bb0495","first-page":"473","article-title":"O-GlcNAcylation and oxidation of proteins: is signalling in the cardiovascular system becoming sweeter?","volume":"123","author":"Lima","year":"1979","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.bbadis.2016.08.012_bb0500","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s00726-010-0728-7","article-title":"Augmented O-GlcNAc signaling attenuates oxidative stress and calcium overload in cardiomyocytes","volume":"40","author":"Ngoh","year":"2011","journal-title":"Amino Acids"},{"key":"10.1016\/j.bbadis.2016.08.012_bb0505","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.yjmcc.2015.10.001","article-title":"Normal and high eNOS levels are detrimental in both mild and severe cardiac pressure-overload","volume":"88","author":"van Deel","year":"2015","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bbadis.2016.08.012_bb0510","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1172\/JCI11235","article-title":"Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site","volume":"108","author":"Du","year":"2001","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2016.08.012_bb0515","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/nature06668","article-title":"Phosphoinositide signalling links O-GlcNAc transferase to insulin resistance","volume":"451","author":"Yang","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2016.08.012_bb0520","doi-asserted-by":"crossref","first-page":"e013","DOI":"10.1621\/nrs.04013","article-title":"Estrogen signaling in the cardiovascular system","volume":"4","author":"Kim","year":"2006","journal-title":"Nucl. Recept. Signal."},{"key":"10.1016\/j.bbadis.2016.08.012_bb0525","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0960-0760(00)00167-9","article-title":"Glycosylation of the murine estrogen receptor-alpha","volume":"75","author":"Cheng","year":"2000","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.bbadis.2016.08.012_bb0530","doi-asserted-by":"crossref","first-page":"11609","DOI":"10.1021\/bi000755i","article-title":"Alternative O-glycosylation\/O-phosphorylation of the murine estrogen receptor beta","volume":"39","author":"Cheng","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbadis.2016.08.012_bb0535","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1365-2443.2008.01260.x","article-title":"AMP-activated protein kinase phosphorylates glutamine: fructose-6-phosphate amidotransferase 1 at Ser243 to modulate its enzymatic activity","volume":"14","author":"Eguchi","year":"2009","journal-title":"Genes Cells"},{"key":"10.1016\/j.bbadis.2016.08.012_bb0540","doi-asserted-by":"crossref","first-page":"10592","DOI":"10.1074\/jbc.M113.523068","article-title":"Cross-talk between two essential nutrient-sensitive enzymes: O-GlcNAc transferase (OGT) and AMP-activated protein kinase (AMPK)","volume":"289","author":"Bullen","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2016.08.012_bb0545","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s11897-012-0102-z","article-title":"AMP-activated protein kinase in the control of cardiac metabolism and remodeling","volume":"9","author":"Horman","year":"2012","journal-title":"Curr. Heart Fail. Rep."},{"key":"10.1016\/j.bbadis.2016.08.012_bb0550","doi-asserted-by":"crossref","DOI":"10.1016\/j.yjmcc.2016.01.001","article-title":"AMPK in cardiac fibrosis and repair: actions beyond metabolic regulation","author":"Daskalopoulos","year":"2016","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bbadis.2016.08.012_bb0555","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1161\/CIRCRESAHA.110.224675","article-title":"O-GlcNAc signaling in the cardiovascular system","volume":"107","author":"Ngoh","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbadis.2016.08.012_bb0560","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.4155\/bio.14.239","article-title":"Proteomic approaches for site-specific O-GlcNAcylation analysis","volume":"6","author":"Wang","year":"2014","journal-title":"Bioanalysis"},{"key":"10.1016\/j.bbadis.2016.08.012_bb0565","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.bbrc.2015.04.114","article-title":"Regulatory O-GlcNAcylation sites on FoxO1 are yet to be identified","volume":"462","author":"Fardini","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbadis.2016.08.012_bb0570","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S1097-2765(04)00211-4","article-title":"The IGF-1\/PI3K\/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors","volume":"14","author":"Stitt","year":"2004","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbadis.2016.08.012_bb0575","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.febslet.2008.02.010","article-title":"O-glycosylation of FoxO1 increases its transcriptional activity towards the glucose 6-phosphatase gene","volume":"582","author":"Kuo","year":"2008","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbadis.2016.08.012_bb0580","doi-asserted-by":"crossref","first-page":"5148","DOI":"10.1074\/jbc.M808890200","article-title":"A PGC-1alpha-O-GlcNAc transferase complex regulates FoxO transcription factor activity in response to glucose","volume":"284","author":"Housley","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2016.08.012_bb0585","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1161\/CIRCULATIONAHA.114.013895","article-title":"Inhibition of hypertrophy, per se, may not be a good therapeutic strategy in ventricular pressure overload: other approaches could be more beneficial","volume":"131","author":"Crozatier","year":"2015","journal-title":"Circulation"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443916302010?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443916302010?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T07:27:34Z","timestamp":1657178854000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443916302010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":117,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S0925443916302010"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2016.08.012","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"O-GlcNAcylation, enemy or ally during cardiac hypertrophy development?","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2016.08.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}